DNA Damage Response in Prostate Cancer.

Area of Science:

• Oncology
• Genetics
• Urology

Background:

• Prostate adenocarcinoma (PCa) is a major health concern, with disseminated disease being uniformly fatal.
• Current treatments for metastatic PCa focus on androgen receptor (AR) signaling suppression, but tumors often develop resistance, leading to castration-resistant PCa (CRPC).
• AR signaling plays a role in DNA repair, and defects in these pathways are associated with PCa progression and poor outcomes.

Purpose of the Study:

• To review DNA repair alterations in clinical PCa settings.
• To explore the molecular and cellular consequences of DNA repair dysfunction in PCa.
• To consider clinical strategies for targeting PCa with altered DNA repair.

Main Methods:

• Literature review of clinical studies and molecular research.
• Analysis of the role of AR signaling in DNA repair pathways.
• Exploration of the link between DNA repair defects and PCa progression.

Main Results:

• Alterations in DNA damage repair pathways are frequently observed in clinical PCa.
• Dysfunctional DNA repair contributes to PCa progression and resistance to therapy.
• AR signaling is implicated in the regulation of DNA repair mechanisms.

Conclusions:

• Targeting DNA repair pathways represents a potential therapeutic strategy for CRPC.
• Understanding DNA repair alterations is crucial for developing effective treatments for advanced PCa.
• Further research is needed to fully elucidate the role of DNA repair in PCa and to develop targeted therapies.